AstraZeneca Statistics

Total Valuation

AstraZeneca has a market cap or net worth of GBP 161.24 billion. The enterprise value is 181.68 billion.

Market Cap	161.24B
Enterprise Value	181.68B

Important Dates

The next estimated earnings date is Tuesday, July 29, 2025.

Earnings Date	Jul 29, 2025
Ex-Dividend Date	Feb 20, 2025

Share Statistics

AstraZeneca has 1.55 billion shares outstanding. The number of shares has increased by 0.08% in one year.

Current Share Class	1.55B
Shares Outstanding	1.55B
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	84.66%
Float	1.54B

Valuation Ratios

The trailing PE ratio is 27.03 and the forward PE ratio is 15.04. AstraZeneca's PEG ratio is 1.41.

PE Ratio	27.03
Forward PE	15.04
PS Ratio	3.79
PB Ratio	5.06
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.41

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.62, with an EV/FCF ratio of 21.05.

EV / Earnings	30.20
EV / Sales	4.27
EV / EBITDA	12.62
EV / EBIT	17.27
EV / FCF	21.05

Financial Position

The company has a current ratio of 0.90, with a Debt / Equity ratio of 0.77.

Current Ratio	0.90
Quick Ratio	0.69
Debt / Equity	0.77
Debt / EBITDA	1.70
Debt / FCF	2.84
Interest Coverage	10.16

Financial Efficiency

Return on equity (ROE) is 19.79% and return on invested capital (ROIC) is 11.73%.

Return on Equity (ROE)	19.79%
Return on Assets (ROA)	8.16%
Return on Invested Capital (ROIC)	11.73%
Return on Capital Employed (ROCE)	17.65%
Revenue Per Employee	451,278
Profits Per Employee	63,791
Employee Count	94,300
Asset Turnover	0.53
Inventory Turnover	1.72

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.17% in the last 52 weeks. The beta is 0.18, so AstraZeneca's price volatility has been lower than the market average.

Beta (5Y)	0.18
52-Week Price Change	-12.17%
50-Day Moving Average	10,606.78
200-Day Moving Average	11,211.98
Relative Strength Index (RSI)	50.92
Average Volume (20 Days)	2,199,792

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AstraZeneca had revenue of GBP 42.56 billion and earned 6.02 billion in profits. Earnings per share was 3.85.

Revenue	42.56B
Gross Profit	35.08B
Operating Income	10.53B
Pretax Income	7.19B
Net Income	6.02B
EBITDA	14.15B
EBIT	10.53B
Earnings Per Share (EPS)	3.85

Full Income Statement

Balance Sheet

The company has 4.18 billion in cash and 24.55 billion in debt, giving a net cash position of -20.37 billion or -13.14 per share.

Cash & Cash Equivalents	4.18B
Total Debt	24.55B
Net Cash	-20.37B
Net Cash Per Share	-13.14
Equity (Book Value)	31.83B
Book Value Per Share	20.49
Working Capital	-2.31B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.13 billion and capital expenditures -1.50 billion, giving a free cash flow of 8.63 billion.

Operating Cash Flow	10.13B
Capital Expenditures	-1.50B
Free Cash Flow	8.63B
FCF Per Share	5.57

Full Cash Flow Statement

Margins

Gross margin is 82.44%, with operating and profit margins of 24.75% and 14.14%.

Gross Margin	82.44%
Operating Margin	24.75%
Pretax Margin	16.90%
Profit Margin	14.14%
EBITDA Margin	33.24%
EBIT Margin	24.75%
FCF Margin	20.28%

Dividends & Yields

This stock pays an annual dividend of 2.38, which amounts to a dividend yield of 2.29%.

Dividend Per Share	2.38
Dividend Yield	2.29%
Dividend Growth (YoY)	7.81%
Years of Dividend Growth	n/a
Payout Ratio	63.60%
Buyback Yield	-0.08%
Shareholder Yield	2.21%
Earnings Yield	3.73%
FCF Yield	5.35%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AstraZeneca has an Altman Z-Score of 3.08.

Altman Z-Score	3.08
Piotroski F-Score	n/a